Trial intelligence / Profile preview

Intravenous paracetamol vs lidocaine for prevention of propofol injection pain

ChiCTR2300076700Phase 4Not yet recruiting

Sponsor
Shenzhen Maternal and Child Health Hospital
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of acetaminophen and lidocaine in propofol injection site pain (PISP) (3 arms), sponsored by Shenzhen Maternal and Child Health Hospital. Primary endpoint: Propofol injection pain score. Planned start Nov 2022; status: not yet recruiting.

02

Drugs

acetaminophenlidocaine
03

Conditions

propofol injection site pain (PISP)

Beyond the preview

Go deeper on ChiCTR2300076700.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300076700.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call